Contact
Please use this form to send email to PR contact of this press release:
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
TO:
Please use this form to send email to PR contact of this press release:
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
TO: